Corcept Therapeutics Inc Liquidation Value

CORT Other

Cash & Equivalents

$120.50M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $120.50M
Total Obligations: -$172.19M
$-51.70M
Per share: $-0.49
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $120.50M
AR: $59.79M
Total Obligations: -$172.19M
$8.09M
Per share: $0.08
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $120.50M
AR: $59.79M
Inventory: $12.87M
Total Obligations: -$172.19M
$20.96M
Per share: $0.20
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-51.70M$-0.49
Liquid Liquidation Value$8.09M$0.08
Operating Liquidation Value$20.96M$0.20

Key Components (as of 2025-12-31)

Cash & Equivalents$120.50M
Accounts Receivable$59.79M
Inventory$12.87M
Current Liabilities$166.09M
Long-term DebtN/A
Op. Lease Liability$6.11M
Finance LeaseN/A
Shares Outstanding106.0M

Explore all 192 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$120.50M$59.79M$12.87M$40.44M$166.09MN/A$6.11MN/A
2025-09-30$125.14M$69.63M$12.35M$34.45M$172.26MN/A$6.36MN/A
2025-06-30$102.75M$64.57M$12.28M$23.52M$144.66MN/A$6.61MN/A
2025-03-31$89.82M$61.82M$14.37M$27.95M$143.07MN/A$6.83MN/A
2024-12-31$127.67M$53.98M$12.41M$15.38M$140.77MN/A$6.94MN/A
2024-09-30$137.29M$59.72M$8.05M$18.58M$126.22MN/A$6.79MN/A
2024-06-30$128.59M$53.84M$8.35M$19.48M$100.75MN/A$5.67MN/A
2024-03-31$149.75M$61.52M$7.19M$12.56M$97.20MN/A$76,000N/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-24 View
2025-09-30 10-Q 2025-11-04 View
2025-06-30 10-Q 2025-07-31 View
2025-03-31 10-Q 2025-05-05 View
2024-12-31 10-K 2025-02-26 View
2024-09-30 10-Q 2024-10-30 View
2024-06-30 10-Q 2024-07-29 View
2024-03-31 10-Q 2024-05-01 View

Community Notes

Loading notes...

Questions

Loading questions...